1. Home
  2. ARBB vs IMRN Comparison

ARBB vs IMRN Comparison

Compare ARBB & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ARB IOT Group Limited

ARBB

ARB IOT Group Limited

SELL

Current Price

$3.70

Market Cap

6.5M

Sector

Technology

ML Signal

SELL

Logo Immuron Limited

IMRN

Immuron Limited

N/A

Current Price

$0.86

Market Cap

7.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ARBB
IMRN
Founded
1997
1994
Country
Singapore
Australia
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
7.7M
IPO Year
2022
2016

Fundamental Metrics

Financial Performance
Metric
ARBB
IMRN
Price
$3.70
$0.86
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.3K
★ 15.2K
Earning Date
12-01-2026
08-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$12.00
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.16
$0.68
52 Week High
$10.67
$1.99

Technical Indicators

Market Signals
Indicator
ARBB
IMRN
Relative Strength Index (RSI) 41.58 37.20
Support Level $3.16 $0.74
Resistance Level $4.95 $0.89
Average True Range (ATR) 0.22 0.06
MACD -0.01 0.01
Stochastic Oscillator 43.45 34.16

Price Performance

Historical Comparison
ARBB
IMRN

About ARBB ARB IOT Group Limited

ARB IOT Group Ltd is a provider of complete solutions to the clients for the integration of Internet of Things (IoT) systems and devices from designing to project deployment. The company offers a wide range of IoT systems as well as provides customers with a substantial range of services such as system integration and system support services. It delivers solutions like designing, installation, testing and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company operates in two reportable segments: (i) the provision of hardware and software of IoT solutions and (ii) Investment holding and others. The majority of revenue is generated from the IoT solutions segment.

About IMRN Immuron Limited

Immuron Ltd is a commercial- and clinical-stage biopharmaceutical company focused on the development and commercialization of specifically targeted polyclonal antibodies. Its oral polyclonal antibodies offer delivery within the GI tract and can target viruses or bacteria and neutralize toxins at mucosal surfaces. The Company markets Travelan in Australia, an over-the-counter orally administered passive immunotherapeutic product indicated to reduce the risk of traveler's diarrhea and minor gastrointestinal disorders. Its products include Travelan, ProIBS and Protectyn. Its segments are Research and Development and Hyper-immune products, with Hyper-immune products generating maximum revenue. Australia generates maximum revenue.

Share on Social Networks: